Skip to content

Finding the Dose of Neostigmine to Reverse Vecuronium Muscle Relaxation in Older Patients undergoing Surgery

To evaluate the optimal dose of Neostigmine antagonizing Vecuronium-induced neuromuscular block in elderly patients: A comparative cohort study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086239
Enrollment
158
Registered
2025-05-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Nil: Nil Control Intervention1: TOFR monitor will be used to find the residual paralysis: Reversal of neuromuscular block by assessing residual paralysis using TOFR monitor Before induc

Sponsors

Ashli Shaji
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Elderly participants undergoing elective surgery of expected duration less than or equal to 3 hours under general anesthesia using neostigmine to antagonize vecuronium-induced muscle relaxation. Participants with ASA physical classification I and II who can provide informed consent

Exclusion criteria

Exclusion criteria: Patients with unexpected perioperative surgical complications, BMI greater than 30 Kg/m2, Patients who have planned postoperative ventilatory support, Patients with more than a 10% difference in two consecutive TOFR, History of neuromuscular, hepatic, and renal disorders, known allergy to neostigmine and vecuronium, usage of the drugs affecting neuromuscular transmission.

Design outcomes

Primary

MeasureTime frame
To compare the optimal dose of Neostigmine to antagonize Vecuronium-induced neuromuscular blockade by assessing residual paralysis using a Train of four ratio V/S clinical assessment tests in geriatric patientsTimepoint: Before induction of general anaesthesia, immediately after intubation 5-15 minutes, Pre-reversal phase, at the time of tracheal extubation, post-extubation period of 5-15 minutes

Secondary

MeasureTime frame
To investigate the occurrence of intraoperative complications of residual muscle paralysis and potential risk factors of an inadequate dose of neostigmine as the reversal agent in geriatric patientsTimepoint: Before induction of general anaesthesia, immediately after intubation 5-15 minutes, Pre-reversal phase, at the time of tracheal extubation, post-extubation period of 5-15 minutes;To assess the association of intraoperative factors influencing the residual effects of Vecuronium in geriatric patientsTimepoint: Before induction of general anaesthesia, immediately after intubation 5-15 minutes, Pre-reversal phase, at the time of tracheal extubation, post-extubation period of 5-15 minutes

Countries

India

Contacts

Public ContactAshli Shaji

Srinivas University, Institute of Allied Health science, Mukka, Mangaluru

ashlishaji1214@gmail.com9188757127

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026